Reparixin in COVID-19 Pneumonia - Efficacy and Safety
Clinical trial NCT04794803 · TERMINATED
Trial details
- NCT number
- NCT04794803
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2020-11-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.